| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00351195 Details | 2008-08-26 Interventional | 2 | - | Capecitabine Etoposide Oxaliplatin Carcinoma Carcinoma, Hepa… Hepatocellular … | Did not meet the criteria for continuation to second stage - | |||
| NCT00000686 Details | 2008-08-26 Interventional | 1 | - | Stavudine AIDS-Related Co… HIV Infections | - - | |||
| NCT00426985 Details | 2008-08-14 Interventional | 3 | - | Ketoprofen Bursitis Tendinopathy Tendonitis | Sufficient number of subjects accrued to conduct analysis - | |||
| NCT00002420 Details | 2008-08-14 Interventional | 2 | - | Delavirdine Didanosine Emivirine Hydroxyurea Stavudine HIV Infections | - - | |||
| NCT00002418 Details | 2008-08-14 Interventional | 2 | - | Didanosine Emivirine Hydroxyurea Nevirapine Stavudine Infections HIV Infections | - - | |||
| NCT00362765 2005-003347-31 Details | 2008-08-13 Interventional | 2/3 | 8 | Fenofibrate Metformin Diabetes Mellit… Dyslipidemias Insulin Resista… Dyslipidemia Type 2 Diabetes | The study was prematurely terminated, due to difficulties in the recruitment of T2DM patients
who are not under statin therapy at inclusion. - | |||
| NCT00170742 Details | 2008-08-12 Interventional | 3 | - | Octreotide Diabetic Retino… Retinal Disease… Proliferative D… | trial stopped on Sept 24, 2007 - | |||
| NCT00380276 Details | 2008-08-05 Interventional | 3 | - | Tarenflurbil Alzheimer Disea… Alzheimer's Dis… | Myriad has discontinued the development of Flurizan. - | |||
| NCT00232349 Details | 2008-07-31 Interventional | 4 | 21 | Galantamine Psychotic Disor… Schizophrenia Psychotic Disor… | Study terminated due to no apparent benefit. - | |||
| NCT00403442 Details | 2008-07-30 Interventional | 1 | - | Bevacizumab Verteporfin Macular Degener… | - - | |||
| NCT00239200 Details | 2008-07-30 Interventional | 2 | - | Lapatinib Carcinoma Carcinoma, Squa… Esophageal Neop… Esophageal Squa… Recurrence Metastatic or R… | notification from sponsor - | |||
| NCT00683436 Details | 2008-07-22 Interventional | 2 | - | Adipiplon Sleep Initiatio… Primary Insomni… | - - | |||
| NCT00156962 Details | 2008-07-21 Interventional | 3 | - | Epoetin Alfa Kidney Diseases Renal Insuffici… Chronic Kidney … | Regulatory decision not to proceed - | |||
| NCT00148018 Details | 2008-07-10 Interventional | 2 | - | Bortezomib Dexamethasone Hodgkin Disease Lymphoma | - - | |||
| NCT00263302 Details | 2008-07-04 Interventional | 1 | - | Dexamethasone Heart Failure Heart Failure, … | - - | |||
| NCT00562198 Details | 2008-06-16 Interventional | 2 | - | Carbidopa Carbidopa, levo… Entacapone Parkinson Disea… Parkinson´s Di… | Illogistical results found in interim evaluation. - | |||
| NCT00539799 2007-003923-20 Details | 2008-05-29 Interventional | 3 | - | Prednisolone Lupus Nephritis Nephritis | Local pharmacy unwilling to comply with study protocol - | |||
| NCT00363610 Details | 2008-05-20 Interventional | 1 | 19 | Pegaspargase Lymphoma Tumors | No recommended Phase II dose was determined. - | |||
| NCT00358566 2005-005014-21 Details | 2008-05-19 Interventional | 3 | 360 | Gemcitabine Pancreatic Neop… Advanced Unrese… | Preliminary data showed no survival benefit in the GV1001 group compared to the gemcitabine
group. - | |||
| NCT00236223 Details | 2008-05-15 Interventional | 4 | 48 | Dexamethasone Gabapentin Ketamine Pain, Postopera… | Structural changes that stopped the type of operations used in the study - |